Literature DB >> 23144328

Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes.

Marinka Kartalija1, Alida R Ovrutsky, Courtney L Bryan, Gregory B Pott, Giamila Fantuzzi, Jacob Thomas, Matthew J Strand, Xiyuan Bai, Preveen Ramamoorthy, Micol S Rothman, Vijaya Nagabhushanam, Michael McDermott, Adrah R Levin, Ashley Frazer-Abel, Patricia C Giclas, Judith Korner, Michael D Iseman, Leland Shapiro, Edward D Chan.   

Abstract

RATIONALE: Among patients with nontuberculous mycobacterial lung disease is a subset of previously healthy women with a slender body morphotype, often with scoliosis and/or pectus excavatum. We hypothesize that unidentified factors predispose these individuals to pulmonary nontuberculous mycobacterial disease.
OBJECTIVES: To compare body morphotype, serum adipokine levels, and whole-blood cytokine responses of patients with pulmonary nontuberculous mycobacteria (pNTM) with contemporary control subjects who are well matched demographically.
METHODS: We enrolled 103 patients with pNTM and 101 uninfected control subjects of similar demographics. Body mass index and body fat were quantified. All patients with pNTM and a subset of control subjects were evaluated for scoliosis and pectus excavatum. Serum leptin and adiponectin were measured. Specific cytokines important to host-defense against mycobacteria were measured in whole blood before and after stimulation.
MEASUREMENTS AND MAIN RESULTS: Patients with pNTM and control subjects were well matched for age, gender, and race. Patients with pNTM had significantly lower body mass index and body fat and were significantly taller than control subjects. Scoliosis and pectus excavatum were significantly more prevalent in patients with pNTM. The normal relationships between the adipokines and body fat were lost in the patients with pNTM, a novel finding. IFN-γ and IL-10 levels were significantly suppressed in stimulated whole blood of patients with pNTM.
CONCLUSIONS: This is the first study to comprehensively compare body morphotype, adipokines, and cytokine responses between patients with NTM lung disease and demographically matched controls. Our findings suggest a novel, predisposing immunophenotype that should be mechanistically defined.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23144328      PMCID: PMC5446199          DOI: 10.1164/rccm.201206-1035OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  62 in total

1.  Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis.

Authors:  Amar Safdar; Dorothy A White; Diane Stover; Donald Armstrong; Henry W Murray
Journal:  Am J Med       Date:  2002-12-15       Impact factor: 4.965

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

3.  The Theodore E. Woodward Award. Mycobacterium avium and slender women: an unrequited affair.

Authors:  M D Iseman
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

4.  Body mass index and incidence of tuberculosis.

Authors:  A Tverdal
Journal:  Eur J Respir Dis       Date:  1986-11

5.  Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex.

Authors:  R Vankayalapati; B Wizel; B Samten; D E Griffith; H Shams; M R Galland; C F Von Reyn ; W M Girard; R J Wallace ; P F Barnes
Journal:  J Infect Dis       Date:  2000-12-20       Impact factor: 5.226

6.  Relation of leptin and tumor necrosis factor alpha to body weight changes in patients with pulmonary tuberculosis.

Authors:  B Cakir; A Yönem; S Güler; E Odabaşi; B Demirbaş; G Gürsoy; Y Aral
Journal:  Horm Res       Date:  1999

7.  Production of cytokines in patients with primary pulmonary Mycobacterium avium-intracellulare complex disease.

Authors:  Mikiko Emori
Journal:  Kurume Med J       Date:  2004

8.  Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology.

Authors:  P Maureen Cassidy; Katrina Hedberg; Ashlen Saulson; Erin McNelly; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

9.  Pulmonary disease in patients with Marfan syndrome.

Authors:  J R Wood; D Bellamy; A H Child; K M Citron
Journal:  Thorax       Date:  1984-10       Impact factor: 9.139

Review 10.  Leptin in the regulation of immunity, inflammation, and hematopoiesis.

Authors:  G Fantuzzi; R Faggioni
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

View more
  73 in total

1.  Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.

Authors:  Eva P Szymanski; Janice M Leung; Cedar J Fowler; Carissa Haney; Amy P Hsu; Fei Chen; Priya Duggal; Andrew J Oler; Ryan McCormack; Eckhard Podack; Rebecca A Drummond; Michail S Lionakis; Sarah K Browne; D Rebecca Prevots; Michael Knowles; Gary Cutting; Xinyue Liu; Scott E Devine; Claire M Fraser; Hervé Tettelin; Kenneth N Olivier; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

Review 2.  The Clinical Significance of Collateral Ventilation.

Authors:  Peter B Terry; Richard J Traystman
Journal:  Ann Am Thorac Soc       Date:  2016-12

3.  Enlarged Dural Sac in Idiopathic Bronchiectasis Implicates Heritable Connective Tissue Gene Variants.

Authors:  M Leigh Anne Daniels; Katherine R Birchard; Jared R Lowe; Michael V Patrone; Peadar G Noone; Michael R Knowles
Journal:  Ann Am Thorac Soc       Date:  2016-10

Review 4.  Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Authors:  In Kwon Park; Kenneth N Olivier
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

5.  Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Steven A Cowman; Joseph Jacob; David M Hansell; Peter Kelleher; Robert Wilson; William O C Cookson; Miriam F Moffatt; Michael R Loebinger
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

6.  Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.

Authors:  S-Y Kim; W-J Koh; H Y Park; K Jeon; O J Kwon; S-N Cho; S J Shin
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

7.  Attenuated heme oxygenase-1 responses predispose the elderly to pulmonary nontuberculous mycobacterial infections.

Authors:  Ranu Surolia; Suman Karki; Zheng Wang; Tejaswini Kulkarni; Fu Jun Li; Shikhar Vohra; Hitesh Batra; Jerry A Nick; Steven R Duncan; Victor J Thannickal; Adrie J C Steyn; Anupam Agarwal; Veena B Antony
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-30       Impact factor: 5.464

8.  The impact of low subcutaneous fat in patients with nontuberculous mycobacterial lung disease.

Authors:  Seok Jeong Lee; Yon Ju Ryu; Jin Hwa Lee; Jung Hyun Chang; Sung Shine Shim
Journal:  Lung       Date:  2014-02-19       Impact factor: 2.584

Review 9.  A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections.

Authors:  Un-In Wu; Steven M Holland
Journal:  Semin Immunopathol       Date:  2016-01-05       Impact factor: 9.623

10.  Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease.

Authors:  Bo Young Lee; Sunyoung Kim; YoonKi Hong; Sang-Do Lee; Woo Sung Kim; Dong Soon Kim; Tae Sun Shim; Kyung-Wook Jo
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.